Why did RDC.DE stock fall sharply today?

RDC.DE stock fell due to heavy selling, weak earnings metrics, and sector pressure. High intraday volume of **176,480.00** shares amplified the move, while technicals turned oversold. News flow and broader European market weakness also contributed.

What are the key support and resistance levels for RDC.DE stock?

Immediate support sits near **€30.00**, with a stronger monthly model level at **€28.50**. Resistance is the day open **€37.10** and the 50-day average **€59.38**. Watch volume before trading a breakout.

How does Meyka AI view RDC.DE stock performance and forecast?

Meyka AI rates RDC.DE **71.40** (Grade B+, Suggestion BUY). The model projects **€28.50** monthly and **€94.27** yearly. Forecasts are projections, not guarantees, and should be used with other analysis.

When is the next earnings date that could move RDC.DE stock?

Redcare Pharmacy’s next earnings announcement is scheduled for **06 May 2026**. Earnings and guidance will likely be the main near-term catalyst for RDC.DE stock.

DE Stocks

RDC.DE down 14.38% intraday 19 Mar 2026: Redcare Pharmacy XETRA risk levels

ByDanny Kontos March 19, 2026

The RDC.DE stock plunged -14.38% intraday to €34.88 on XETRA on 19 Mar 2026, making Redcare Pharmacy one of today’s top losers. Volume reached 176,480.00 shares, nearly double the average, as traders reacted to continued profit concerns and sector pressure in Healthcare. We review what drove the move, the technical support to watch, and how our models and proprietary Meyka grade frame near-term risk and longer-term upside for Redcare Pharmacy N.V.